Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Egyptian Pharmaceutical Trading Company (EPTC), widely known as Al-Masriya, is the leading state-owned pharmaceutical distributor and importer in Egypt. Founded in 1965, the company operates as a strategic arm of the Egyptian government under the Drug Holding Company (HoldiPharma) to ensure the national supply of essential and life-saving medications. EPTC holds exclusive rights to import specialized treatments, including oncology drugs, biotechnology products, and narcotics, and is a primary provider of insulin and infant formula. With a vast infrastructure comprising 78 pharmacies and 48 sales branches, the company provides comprehensive logistics and distribution services to the entire Egyptian healthcare sector, including public hospitals and private pharmacies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Egyptian Pharmaceutical Trading Company.